|Day Low/High||142.33 / 144.00|
|52 Wk Low/High||92.98 / 137.54|
Celgene Corporation (NASDAQ:CELG) today announced that the U.S.
More Immunotherapy Buyouts Likely After Kite Sale
Jim Cramer takes his stock picks -- like his fantasy football picks -- very, very seriously.
This team is playoff-ready and built for the ages.
From political signals to the rebuilding and recovery efforts in Texas, Jim Cramer says investors should pay attention to what's supporting stocks.
Buying's good for the acquirers, which should give other companies ideas.
Prospects for acquisition activity in the sector are improving.
Celgene Corporation (NASDAQ:CELG) plans to present at four upcoming investor conferences where Celgene management will provide an overview of the Company.
Nothing's happening, but that doesn't mean you have to make something happen.
The market seems fully valued, so I'm building up cash as we head into historically volatile months.
CELG looks like it has a promising future, according to the charts.
Celgene Corporation (NASDAQ:CELG) and Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) today announced that IDHIFA ® (enasidenib) was granted approval from the U.
Multiples have become quite rich and dysfunction in Washington could end up biting the markets.
Celgene Corporation (NASDAQ:CELG) plans to present at an upcoming investor conference where Celgene management will provide an overview of the Company.
The Nasdaq tumbles and the S&P 500 slides. The Dow rises slightly.
Celgene Corporation (NASDAQ:CELG) reported net product sales of $3,256 million for the second quarter of 2017, a 19 percent increase from the same period in 2016.
U.S. stock futures point higher after Facebook shares jump.
Celgene Corporation (NASDAQ:CELG) today announced that it has reached a civil settlement with Relator Brown, the Department of Justice, 28 States, the District of Columbia, and the City of Chicago to resolve the previously...
Celgene had been accused of marketing off-label uses for two of its cancer treatments.
Stock prices are either unfairly dragged down by competitors' earnings news or by Amazon's spread into more businesses, Cramer said.
Wall Street's first glimpse at the second quarter.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.